Literature DB >> 7687281

Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).

H Hörtnagl1, M L Berger, L Havelec, O Hornykiewicz.   

Abstract

Glucocorticoids potentiate hippocampal damage induced by various noxious insults in vivo and in vitro and are implicated in age-related loss of neurons in the hippocampus of various species. The cholinergic innervation of the hippocampus appears to be especially prone to the endangering effect of glucocorticoids, since corticosterone, like acute stress or ACTH, induces a rapid activation of the cholinergic septo-hippocampal pathway. We now report the influence of glucocorticoids on the degeneration of this pathway induced by the cholinergic neurotoxin ethylcholine aziridinium (AF64A). The toxic effect of a submaximal dose of AF64A on cholinergic neurons was evaluated in rats during exposure to glucocorticoids or vehicle as well as in adrenalectomized or sham-operated rats. Daily treatment with either corticosterone or dexamethasone, starting 7 d before the bilateral intracerebroventricular injection of AF64A (1 nmol/ventricle), significantly increased the AF64A-induced loss of ChAT activity in the whole hippocampus, whereas bilateral adrenalectomy 7 d prior to AF64A-injection attenuated the effect of AF64A. Short-term exposure to corticosterone starting 24 hr before AF64A was as effective as the 7 d pretreatment. Dexamethasone exacerbated the AF64A-induced cholinergic lesion in the hippocampal subregions CA1, CA3, and dentate gyrus, and adrenalectomy protected all subregions against the action of AF64A. Along the longitudinal axis of the hippocampus a comparable influence was seen in the dorsal and ventral parts. The subregional pattern in the response to glucocorticoid suggests the involvement of mineralocorticoid type I receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687281      PMCID: PMC6576693     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  7 in total

1.  Binge-like ethanol consumption increases corticosterone levels and neurodegneration whereas occupancy of type II glucocorticoid receptors with mifepristone is neuroprotective.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Carol Hamelink; Michael Brunnquell; Annika Thorsell; Markus Heilig; Robert L Eskay
Journal:  Addict Biol       Date:  2012-04-13       Impact factor: 4.280

2.  Concentration dependent actions of glucocorticoids on neuronal viability and survival.

Authors:  István M Abrahám; Peter Meerlo; Paul G M Luiten
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

3.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

4.  Impact of Chronic Stress on the Spatial Learning and GR-PKAc-NF-κB Signaling in the Hippocampus and Cortex in Rats Following Cholinergic Depletion.

Authors:  Sun-Young Lee; Woo-Hyun Cho; Yo-Seob Lee; Jung-Soo Han
Journal:  Mol Neurobiol       Date:  2017-05-27       Impact factor: 5.590

5.  Altered neurochemical ingredient of hippocampus in patients with bipolar depression.

Authors:  Murad Atmaca; Hanefi Yildirim
Journal:  Depress Res Treat       Date:  2012-03-01

6.  Chemically Bonding of Amantadine with Gardenamide A Enhances the Neuroprotective Effects against Corticosterone-Induced Insults in PC12 Cells.

Authors:  Jiaqiang Zhao; Lizhi Peng; Wenhua Zheng; Rikang Wang; Lei Zhang; Jian Yang; Heru Chen
Journal:  Int J Mol Sci       Date:  2015-09-21       Impact factor: 5.923

Review 7.  Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment.

Authors:  Saswati Paul; Won Kyung Jeon; Jennifer L Bizon; Jung-Soo Han
Journal:  Front Aging Neurosci       Date:  2015-04-02       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.